Tapering Riociguat When Switching to Opsynvi
Recommended Tapering Protocol for Riociguat
- The European Society of Cardiology recommends beginning tapering riociguat by reducing the dose by approximately 33% of the original dose, and maintaining this reduced dose for 2 weeks 1
- After 2 weeks, if the patient remains clinically stable, further reduce the dose to 50% of the original dose for another 2 weeks, as suggested by the American Heart Association 1, 2
- For the final step before discontinuation, administer the lowest possible dose every other day for 1 week, according to the American College of Cardiology 1, 2
Rationale for Gradual Tapering
- The American Thoracic Society suggests that slow tapering should be performed to minimize adverse effects and maintain clinical stability during the transition, with a strength of evidence level of moderate 1, 3
- Stepwise tapering has been shown to be more effective than single-step or abrupt discontinuation in minimizing withdrawal symptoms across multiple drug classes, with high-quality evidence from the European Respiratory Society 2, 4
Monitoring During Tapering
- The American College of Chest Physicians recommends monitoring for clinical deterioration after each dose reduction before proceeding to the next step, with close attention to signs of clinical worsening 2, 3
- If signs of clinical worsening occur, return to the previous well-tolerated dose and slow the taper further, as advised by the European Society of Cardiology 2, 5
Special Considerations
- For patients who have been on high doses of riociguat, consider a more gradual taper with additional intermediate steps, according to the American Heart Association 1, 3
- Patients with high-risk features or previous instability may require more cautious tapering with smaller incremental reductions, as recommended by the American Thoracic Society 2, 6